Today's Veterinary Business

AUG 2018

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link: https://todaysveterinarybusiness.epubxp.com/i/1007483

Contents of this Issue

Navigation

Page 41 of 75

34 Today's Veterinary Business Business Vetalytix is the industry's largest repository of localized economic insight, regulatory compliance and pharmacy support tools, all of which are designed to help the private practitioner compete in today's challenging economy. Vetalytix is an open community available as a resource to the veterinary profession and is sponsored by the NAVC, Today's Veterinary Business and leading animal health distributors. For more detailed infor- mation related to your local market, go to www.vetalytix.com. Canine and feline core vaccine volumes, which were both mildly nega- tive compared to the prior year, showed above-average growth during the spring months. Canine influenza dose utilization increased when compared to the prior year, consistent to the broader adoption of the antigen as a critical component of vaccination protocols. Procedural volume and flea and tick dose volume were both off from the second quarter of 2017, but not significantly less impacted than the effects observed nationally. Mountain For the second quarter in a row, overall veterinary business metrics for the Mountain states were positive compared to broader national trends. Overall clinical volume was up almost 6 percent compared to the sec- ond quarter of 2017, double the growth rate observed on a national scale. Canine and feline core vaccine volumes were both positive. Canine core doses were up 7.4 percent compared to second-quarter 2017 values and feline doses showed positive growth at almost 5 percent. Canine influenza volume continued to show tremendous growth, far outpacing the national averages. Procedural volume, although negative, was less impacted than other areas of the country compared to the second-quarter of 2017. Flea and tick dose volume recovered significantly during the second quarter, up almost 15 percent compared to the same period in 2017. Pacific In the second quarter of 2018, the Pacific states continued to observe posi- tive business metrics compared to other parts of the country. Overall clinical volume was up almost 4 percent compared to the first quarter of 2017, still outpacing the national average but slightly lower than the 4.8 percent growth observed in the first quarter of 2018. Canine and feline core vaccine volumes, both relatively ahead of the first-quarter broader market, appeared to have slowed somewhat in the second quarter, with canine core volumes down 2.2 percent and feline core volumes slightly positive at 1.7 percent. Canine influenza utilization appears to still be exploding, up signifi- cantly from the second quarter of 2017 and far outpacing adoption rates on a national scale. Procedural volume, although negative, was less impacted than other areas of the country compared to 2017. Flea and tick dose volume remained off from the second quarter of 2017, but not as impacted as the effects observed nationally. Summary For the second quarter in a row, data reveals that the markets and market dynamics for veterinary medicine are very different depending on the part of the country you're in. As a result, veterinary practices and the challenges they face are just as diverse. Data from the second quarter of 2018 suggests better overall market conditions for veterinary practices compared to the tepid start observed in the first quarter. Some categories, such as overall clinical volume, appear to show marked improvements across the board compared to the disappoint- ing first-quarter results seen in many regions. Other categories, such as flea and tick dose volumes, continued to show challenges in the second quar- ter, suggesting broader issues might be impacting the veterinary practice as a channel. But there's no doubt that some areas have significantly more chal- lenges to face while others have positive dynamics to build off of for the remainder of 2018. Understanding these dynamics and the role they play in your market can provide insight into better meeting the needs of your patients and clients. East North Central (Great Lakes) Q2 2018 Q2 2018 National Vet Consumption Index (Overall Clinical Volume) 2% 3% Canine Core Vacc Doses 2.6% 1.6% Canine Flu Vacc Doses 9.2% -18.6% Feline Core Vacc Doses 6.3% 3.3% Advanced Procedural Volume (Inhalant Anesth. Dynamics) -16.2% -14.7% Flea Tick Doses -8.6% -8.3% Mountain Q2 2018 Q2 2018 National Vet Consumption Index (Overall Clinical Volume) 6% 3% Canine Core Vacc Doses 7.4% 1.6% Canine Flu Vacc Doses 114.2% -18.6% Feline Core Vacc Doses 4.8% 3.3% Advanced Procedural Volume (Inhalant Anesth. Dynamics) -10.2% -14.7% Flea Tick Doses 14.7% -8.3% Pacific Q2 2018 Q2 2018 National Vet Consumption Index (Overall Clinical Volume) 4% 3% Canine Core Vacc Doses -2.2% 1.6% Canine Flu Vacc Doses 197.3% -18.6% Feline Core Vacc Doses 1.7% 3.3% Advanced Procedural Volume (Inhalant Anesth. Dynamics) -8.5% -14.7% Flea Tick Doses -0.6% -8.3% WEST MIDWEST NORTHEAST Pacific Mountain West North Central East North Central Middle Atlantic New England West South Central East South Central South Atlantic SOUTH Source: U.S. Census Bureau Business THE VETALYTIX REPORT

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Business - AUG 2018